Log in to search using one of your social media accounts:

 

Analysts: Japan approves 12 new procedures for Intuitive Surgical ’ s da Vinci
Intuitive Surgical (NSDQ:ISRG) recently won approval for an additional 12 procedures in Japan using its da Vinci robot-assisted surgery devices, according to analysts at Leerink Partners. The approvals could represent an additional 200,000 cases in Japan, up from 30,000, Leerink analysts Richard Newitter and Jaime Morgan wrote this morning in a note to investors, citing talks with management, company reports and Leerink Partners estimates. Previously only cleared for prostatectomy and nephrectomy in Japan, da Vinci is now approved for additional colorectal, gynecological and thoracic surgeries, plus gastrect...
Source: Mass Device - January 18, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Regulatory/Compliance Robotics Wall Street Beat Intuitive Surgical Source Type: news

Obesity Treatments Compared: Bariatric Surgery vs. Nonsurgical Options, Laparoscopic Sleeve Gastrectomy vs. Bypass
Studies in JAMA's obesity issue offer additional evidence on bariatric surgery's benefits and may ease potential concerns over increasing use of laparoscopic sleeve gastrectomy. First... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 17, 2018 Category: Primary Care Source Type: news

Fundoplication for GERD: Laparoscopic Nissen Bests Transoral Incisionless Fundoplication for GERD: Laparoscopic Nissen Bests Transoral Incisionless
Laparoscopic Nissen fundoplication (LNF) appears to be a better alternative than transoral incisionless fundoplication (TIF) for treating gastroesophageal reflux disease (GERD), according to a systematic review and network meta-analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 16, 2018 Category: Surgery Tags: Gastroenterology News Source Type: news

Hiatal Repair During Laparoscopic Sleeve Gastrectomy May Limit GERD Symptoms Hiatal Repair During Laparoscopic Sleeve Gastrectomy May Limit GERD Symptoms
Repair of hiatal laxity and herniation during laparoscopic sleeve gastrectomy (LSG) for obesity improves symptoms of gastroesophageal reflux disease (GERD), according to a new study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 11, 2018 Category: Surgery Tags: Gastroenterology News Source Type: news

Prevalence of Musculoskeletal Disorders Among Surgeons Prevalence of Musculoskeletal Disorders Among Surgeons
Are surgeons who perform laparoscopic surgery at a greater risk for developing musculoskeletal disorders?Annals of Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

FDA Review Confirms Risk from Power Morcellators in Spreading Uterine Cancer
The FDA confirms that power morcellation used for laparoscopic myomectomy or hysterectomy for uterine fibroids is associated with increased risk for spreading cancer. The review... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 18, 2017 Category: Primary Care Source Type: news

Contrast - Enhanced Ultrasound No Aid for Metastasis Detection
Findings based on use of laparoscopic ultrasonography during colorectal cancer surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 15, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Surgery, Journal, Source Type: news

FDA posts new info about using laparoscopic power morcellators to treat uterine fibroids https://go.usa.gov/xnnnS   #morcellator #safety #medicaldevice
FDA posts new info about using laparoscopic power morcellators to treat uterine fibroids https://go.usa.gov/xnnnS  #morcellator #safety #medicaldevice (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - December 14, 2017 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Why a Two-Pound Robot is Getting Love from Investors
About two-thirds of colon resection procedures are performed via open surgery with an eight- to 12-inch incision and several weeks of recovery time. A miniature robotically assisted surgical device (RASD) developed by a company called Virtual Incision could change that.  Virtual Incision is just about ready to go to FDA seeking a 510(k) clearance for its two-pound RASD that operates entirely inside the body through a single abdominal incision and is expected to be less expensive and more portable than existing laparoscopic surgery robots. To help it get there, investors recently poured $18 million into ...
Source: MDDI - December 13, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business R & Source Type: news

How Safe Is Laparoscopic Surgery for Adhesive SBO? How Safe Is Laparoscopic Surgery for Adhesive SBO?
Dr Lowenfels comments on a study that cautions surgeons using a laparoscopic approach for treating a bowel obstruction.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2017 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news

Light at the end of the hysterectomy tunnel – Anne-Marie ’ s story
The post Light at the end of the hysterectomy tunnel – Anne-Marie’s story appeared first on Hysterectomy Association. I gave myself a light at the end of the hysterectomy tunnel as I believe in putting all my chances on my side when it comes to surgeries. I researched and prepared myself well before my hysterectomy. For ex; what to eat, before and after, making sure I bring home meds that do not cause constipation… I had a chart on the fridge that reminded me what I can or cannot do on a weekly basis, (it also helped my husband realise how long a process it was!). I looked forward to the coming weeks whi...
Source: The Hysterectomy Association - November 28, 2017 Category: OBGYN Authors: Linda Tags: Your Stories abdominal hysterectomy Source Type: news

Did TransEnterix Grease Palms to Sell a Robot?
After a longer-than-expected trek to bring a surgical robot to the U.S. market, TransEnterix finally won FDA clearance in October for its Senhance Surgical Robotic System, making it the first new market entrant into the field of abdominal surgical robotics since 2000. The company's stock price jumped after the news was announced, and rallied again when TransEnterix announced its first U.S. sale to Florida Hospital Orlando a month later. For those who have watched Morrisville, NC-based TransEnterix endure many trials and tribulations over the past few years, it seemed as though the company's persistence had finall...
Source: MDDI - November 27, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Common shoulder surgery may offer little pain relief
Study questions value of subacromial decompression Related items fromOnMedica Sharp rise in year-long waits for elective surgery Consultant-led assessments could cut unnecessary surgery Robotic-assisted surgery is not always preferable to laparoscopic Adhesive capsulitis Managing sports injuries: shoulder rotator cuff injury (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 21, 2017 Category: UK Health Source Type: news

TransEnterix opens the doors to a competitive US surgical robotics market
The surgical robotics market in the US has finally become competitive. In October, the FDA granted clearance to only the second robotic surgical system to date – TransEnterix‘s (NYSE:TRXC) Senhance laparoscopic platform. The clearance was a huge milestone for the Morrisville, N.C.-based company and was quickly followed by yet another – almost exactly a month after receiving a nod from the federal watchdog, TransEnterix logged its 1st sale of the platform to the Orlando-based Florida hospital. Read the whole story on our sister site, The Robot Report The post TransEnterix opens the doors to a competit...
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Robotics TransEnterix Source Type: news

Tanzania:Laparoscopy Surgery Proves Wonders At KCMC
[Daily News] TANZANIA has introduced the first-ever day care laparoscopy surgery, which offers great potentials of relieving patients of pains and significantly reducing congestions in hospital. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 20, 2017 Category: African Health Source Type: news

Gynecology Group Names 5 Treatments, Procedures to Avoid
The AAGL (formerly, the American Association of Gynecologic Laparoscopists) has named five treatments and procedures clinicians should question as part of the American Board of... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 17, 2017 Category: Primary Care Source Type: news

Laparoscopic Sleeve Gastrectomy: Good Operation, With Limits Laparoscopic Sleeve Gastrectomy: Good Operation, With Limits
Now the most widely performed bariatric-surgery procedure, laparoscopic sleeve gastrectomy is safer than bypass in the short term but may fall short beyond 7 years out.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Robotic-assisted or conventional laparoscopic  surgery?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

Robotic Surgery: No Clinical Benefit Over Laparoscopy Robotic Surgery: No Clinical Benefit Over Laparoscopy
Patients undergoing robotic-assisted surgery appear to experience no clinical benefit compared with those having conventional laparoscopic procedures, despite a much higher cost, two studies suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 30, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

A rare case of bullhorn-injury associated traumatic hernia of anterior abdominal wall managed by laparoscopic sutured tissue-only repair - Singh KD, Singh V, Gupta P, Mani R.
Traumatic abdominal wall hernias (TAWHs) are relatively uncommon entities. Common mechanisms that predispose to such hernias include motor vehicle accidents, seat belt injuries, fall from height, handlebar injuries, and bullfighting. Bullhorn injury leadin... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Robotic-Assisted Surgery Adds Time, Costs Without Affecting Outcomes (CME/CE)
(MedPage Today) -- No improvements compared with laparoscopic procedures in kidney removal and rectal cancer (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - October 26, 2017 Category: Urology & Nephrology Source Type: news

Robotic Radical Nephrectomy Becoming More Common
And robotic laparoscopy for rectal cancer resection does not reduce risk for conversion to open surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 26, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Nephrology, Oncology, Surgery, Journal, Source Type: news

Robotic-assisted surgery is not always preferable to laparoscopic
Robotic-assisted surgery does not improve some outcomes in kidney removal and rectal cancer procedures Related items fromOnMedica Bariatric surgeons ’ skill doesn’t affect long-term outcomes Bed crisis leaves surgeons 'kicking their heels' Trial of robotic surgery successful for prostate cancer Shortage of critical beds and surgeons cause cancelled ops (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 25, 2017 Category: UK Health Source Type: news

Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
TAIPEI, Taiwan, Oct. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose™... Devices, Surgery Medeon Biodesign, AbClose, laparoscopy, port site wound closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 20, 2017 Category: Pharmaceuticals Source Type: news

TransEnterix CEO Pope, riding high on FDA nod, eyes the laparoscopic surgery market
Share prices for TransEnterix (NYSE:TRXC) have more than doubled since the robot-assisted surgery company won an important clearance from the FDA last week and CEO Todd Pope is optimistic about his companies chances against the undisputed market leader, Intuitive Surgical (NSDQ:ISRG). Morrisville, N.C.-based TransEnterix, which acquired Senhance for $100 million in September 2015, finalized its clearance bid last month after applying in April; the federal safety watchdog granted 510(k) clearance last week, pushing TRXC shares up 92.5% to a $2.81 close yesterday; the stock had ga...
Source: Mass Device - October 17, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Robotics Wall Street Beat TransEnterix Source Type: news

FDA Clears New Robotic Surgery System FDA Clears New Robotic Surgery System
The Senhance System (TransEnterix Surgical Inc) includes unique technological characteristics and is intended for use in laparoscopic colorectal and gynecologic surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2017 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

TransEnterix Thought it Could – and Did
Bringing a surgical robotic system to the U.S. market proved to be an uphill climb for TransEnterix, but just like "The Little Engine That Could," persistence paid off. FDA cleared the company's Senhance Surgical Robotic System, formerly known as the ALF-X System, late last week. The company's shares jumped more than 95% ($1.40) Monday [NYSE: TRXC] on above-average trading volume and ended the day at $2.81. Morrisville, NC-based TransEnterix acquired the system in 2015 and dedicated extra effort last year to conducting in-depth usability studies to satisfy FDA expectations. The Senhance is now...
Source: MDDI - October 16, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Regulatory and Compliance Source Type: news

Spearheading Advancements in Surgical Sealants
Surgeons and clinicians have used surgical sealants for closing or reconnecting ruptured tissues, or as an adjunct to sutures and staples, for years. However, advancements in technology have led general surgeons and specialists to consider sealants for a wider range of applications and with increased frequency. Increasing Ease of Use Surgical sealants aren't as easy to use as a tube of Crazy Glue. Surgeons must mix and use some agents precisely and promptly to be effective. Delivery systems vary from a syringe, proprietary applicator, or through an endoscope. Most require special training. Sylys®, an elastic, resorbabl...
Source: MDDI - October 13, 2017 Category: Medical Devices Authors: Heather R. Johnson Tags: Implants Source Type: news

Olympus launches joint Sony-developed Orbeye 4K-3D video microscope
Olympus (TYO:7733) said today it launched its Orbeye 4K-3D video microscope developed by Sony Olympus Medical solutions, a joint venture between Olympus and Sony‘s (TYO:6758) Imaging Products & Solutions biz. The company said the Orbeye microscope is designed to provide high-resolution 3D imaging of the structure of tissue, blood vessels and other features to enable more accurate surgery. The system includes a 55-inch display to allow for simultaneous surgical team viewing. “The Orbeye exoscope represents the next generation of operative imaging- a true quantum shift. Its adoption is certain and w...
Source: Mass Device - October 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Olympus Sony Corp. Source Type: news

Outcome'Trade-off' With Open, Robotic Prostatectomy Outcome'Trade-off' With Open, Robotic Prostatectomy
There may be a trade-off between early recovery of erectile function and lower rates of positive surgical margins (PSMs) with robot-assisted laparoscopic radical prostatectomy and open retropubic surgery, respectively, a nonrandomized study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 3, 2017 Category: Surgery Tags: Urology News Source Type: news

TransEnterix responds to FDA more info request
Robotics medical company TransEnterix filed its response to the Food and Drug Administration’s additional information request on its Senhance Surgical Robotic System 510(k) submission. The Senhance robotic-assisted surgery system is designed to improve minimally invasive surgery, namely in laparoscopy operations, through haptic feedback and eye sensing camera control. Get the full story at our sister site, The Robot Report. The post TransEnterix responds to FDA more info request appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - September 18, 2017 Category: Medical Devices Authors: Alex Beall Tags: Food & Drug Administration (FDA) Regulatory/Compliance Robotics Wall Street Beat TransEnterix Source Type: news

Selena Gomez Had a Kidney Transplant for Lupus. What Is That?
This article originally appeared on Health.com (Source: TIME.com: Top Science and Health Stories)
Source: TIME.com: Top Science and Health Stories - September 14, 2017 Category: Consumer Health News Authors: Amanda MacMillan / Health Tags: Uncategorized celebrities kidney transplant lupus lupus symptoms public health Selena Gomez Selena gomez disease Selena gomez Kidney Transplant Selena Gomez lupus what disease does selena gomez have What is lupus Why did selena gomez Source Type: news

Endometriosis and the gift of motherhood
When my first period came at age 13, it involved blood clots and extreme pain. I didn’t know what to expect or what was considered “normal,” but thankfully, my mother did. She recognized that my symptoms were unusual and immediately took me to see my pediatrician. I was first prescribed birth control pills, which seemed to help initially, but when my period remained heavy and painful, I was put on a different birth control pill that enabled me to have my period only four times a year. I thought my situation was normal – albeit uncomfortable and inconvenient. No one ever suggested that painful period...
Source: Thrive, Children's Hospital Boston - September 14, 2017 Category: Pediatrics Authors: Alice Hales Tags: Our Patients’ Stories Teen Health endometriosis Marc Laufer Source Type: news

Trial compares laparoscopic and open surgeries for pancreatic cancer
(Wiley) A randomized clinical trial has compared keyhole (laparoscopic) surgery and open surgery in pancreatic cancer patients undergoing pancreaticoduodenectomy, or the Whipple procedure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 13, 2017 Category: International Medicine & Public Health Source Type: news

GERD Recurrence Fairly Common Following Laparoscopic Antireflux Surgery (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Recurrence of gastroesophageal reflux disease (GERD) is relatively common among patients who have laparoscopic antireflux surgery, potentially diminishing some of the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

High Rate of GERD Recurrence After Antireflux Surgery High Rate of GERD Recurrence After Antireflux Surgery
Nearly 18% of patients who undergo primary laparoscopic antireflux surgery will experience recurrent gastroesophageal reflux disease requiring long-term medication or a secondary surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Acessa Health touts data from 10-year review of uterine fibroid treatment
Acessa Health today touted data from a 10-year systematic review and meta-analysis of its Acessa system designed to treat uterine fibroids and comparable procedures, touting reduced blood loss, hospitalization time and readmission rates. Data from the 10-year review was presented at the MIS Week 2017 conference by Dr. Yelena Havryliuk of Weill Cornell Medical College. The review included assessments of 143 journal articles from between 2006 and 2016 and a quantitative synthesis of 45 studies during that time, Austin, Texas-based Acessa Health said. “I have used the Acessa System and been impressed with minimal blood ...
Source: Mass Device - September 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Women's Health acessahealth Source Type: news

Can Next-Gen Obesity Balloon Pump Confidence in Apollo?
Apollo Endosurgery's Orbera365 weight-loss balloon works the same way as the original Orbera device, except it is designed to stay in the patient's stomach for 12 months, twice as long as the previous version. Apollo Endosurgery said it has received CE Mark approval to sell its Orbera365 weight-loss system in Europe, doubling the amount of time the balloon stays inflated in the patient's stomach. The approval comes less than a month after FDA alerted doctors of patient deaths associated with obesity balloons made by Apollo and ReShape Medical. The news deflated Apollo's stock (NASDAQ: APEN), as shares sold o...
Source: MDDI - September 6, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

MIRO trial: 3-year outcomes favor laparoscopic surgery for esophageal cancer
(European Society for Medical Oncology) Patients requiring surgery for esophageal cancer fare better after undergoing a hybrid minimally invasive esophagectomy compared to an open esophagectomy, according to long-term results of the MIRO trial to be presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 4, 2017 Category: Cancer & Oncology Source Type: news

Ethicon touts progress on multi-year bariatric surgery evidence initiative
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it has made major progress in its “Project Game Changer” initiative which looks to close evidence gaps and reduce clinical and economic barriers for access to surgical treatments for treating obesity and related diseases. With the Game Changer Initiative, the company said it is focusing its research and evidence generation efforts on the safety and effectiveness of bariatric surgery on reducing obesity and obesity-related diseases, including type 2 diabetes, heart diseases and orthopedic conditions. “A wide range of evidence guides i...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Weight loss Ethicon johnsonandjohnson Source Type: news

Rwanda: Indian Firm to Set Up Surgery Centre of Excellence in Rwanda
[New Times] Sunrise Group of Hospitals, a specialized consultative care and treatment centre and widely recognized as a pioneer in Laparoscopic and Endoscopic Surgeries, plans to set up a centre of excellence in Rwanda. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 28, 2017 Category: African Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 22, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Silver and electricity can kill bacteria: Here’s how Swedish researchers have developed a way to use silver nanoparticles and electrical currents to prevent bacteria from growing on plastic surfaces – helping to pre...
Source: Mass Device - August 22, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Titan Medical adds French hospital site to future Sport feasibility & validation study
Titan Medical (TSX:TMD) said today it inked a deal with the French Institut Hospitalo-Universitaire de Strasbourg to participate in feasibility and validation studies of its Sport robotic surgical system as the company seeks regulatory clearance for the platform. Toronto-based Titan Medical said it expects to initiate studies of its Sport system in the 4th quarter of this year, continuing into next year. “We are thrilled to partner with IHU Strasbourg, one of Europe’s premier research and training centers, for continued feasibility and validation studies for the Sport system. IHU Strasbourg is well kn...
Source: Mass Device - August 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Robot-Assisted Surgery Robotics Titan Medical Inc. Source Type: news

J & J ’ s Ethicon launches ProxiSure laparoscopic suturing device
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it launched the ProxiSure laparoscopic suturing device. Ethicon said the device features its endomechanical, suture and curved needle technologies to improve suturing precision in tight spaces. The device allows surgeons to reach desired angles, control bites and secure nots during suturing and knot tying to reduce the risk of needle loss, the company added. “With the patient’s health at the forefront of our thinking, we aimed to introduce a suturing device that will help reduce the margin of error in minimally-invasive surgery. Surgeons will n...
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blog Ethicon johnsonandjohnson Source Type: news

Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Advanced laparoscopic suturing device features Ethicon's innovative endomechanical, suture and curved needle technologies SOMERVILLE, N.J., Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Ethicon*, part of the Johnson & Johnson Medical Devic... Devices, Surgery, Product Launch Ethicon, Johnson & Johnson, ProxiSure, Suturing Device, laparoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2017 Category: Pharmaceuticals Source Type: news

Robot arm could revolutionise routine surgery
Laparoscopic, colorectal, prostate and ENT procedures could be simplified and made faster Related items fromOnMedica Six-month-plus surgery waits triple in four years Sharp rise in year-long waits for elective surgery Consultant-led assessments could cut unnecessary surgery Set up protocols to iron out differences in emergency surgery, hospitals told (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 21, 2017 Category: UK Health Source Type: news

Report: Olympus study of next-gen power morcellator draws criticism
Olympus (TYO:7733) is receiving criticism after moving forward with plans to revitalize its powered morcellator devices, with a new 140-patient trial planned, according to a Philadelphia Inquirer report. Power morcellators, which use a cutting tip to shred and remove uterine tissue, have been implicated in the spread of a lethal cancer that can masquerade undetected as benign fibroids. The devices designed to be used to remove benign uterine fibroids, but when used on malignant tissue, can spread cancerous cells throughout the abdomen. Olympus won FDA 510(k) clearance for a next-generation laparoscopic PK morcellator,...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Oncology Source Type: news

Intuitive Surgical licenses JustRight ’ s robotic sealing, stapling tech
Intuitive Surgical (NSDQ:ISRG) inked a license on the miniaturized robotic sealing and stapling technology developed by JustRight Surgical that includes an unspecified equity investment and joint product development program. Louisville, Colo.-based JustRight raised an $11 million Series B round early last year and later won 510(k) clearance from the FDA for its 3mm pediatric vessel-sealing system. “We are excited to team up with Intuitive Surgical to expand the impact of JustRight Surgical’s technology beyond pediatric patients,” CEO Robert Kline said in prepared remarks. “The collabo...
Source: Mass Device - August 9, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Robot-Assisted Surgery Robotics Wall Street Beat intuitivesurgical JustRight Surgical Source Type: news

Fortimedix launches short instruments for SymphonX single-port platform
Fortimedix Surgical said today it launched a shorter set of instruments for its SymphonX single-port surgical platform in the US. The newly launched product line offers shorter instrumentation for use with the SymphonX surgical platform, a single-port system designed for microlaparoscopic surgical procedures, Fortimedix said. The instrument portfolio for the SymphonX system includes products for grasping, mobilizing, dissecting, retracting, cutting, cauterizing, ligating and suction and irrigation of tissues and vessels, the Netherlands-based company said. “This product line extension was developed in response to sur...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Surgical Fortimedix Source Type: news

Mauna Kea wins FDA nod for CelioFlex Cellvizio miniprobes
Mauna Kea (ENT:MKEA) said today it won FDA 510(k) clearance for its CelioFlex UHD confocal miniprobes designed for use with its Cellvizio device in robotic-assisted surgery. The CelioFlex UHD probes are designed to provide visualization of body cavities, organs and canals during endoscopic, laparoscopic and robotic-assisted procedures, the Paris-based company said. “This new FDA clearance is an important milestone for the company on its Cellvizio product roadmap and market expansion strategy. We see the ability to instantaneously visualize and characterize tissue at the cellular level as a natural extension to r...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Mauna Kea Technologies Source Type: news